U.S. Markets open in 5 hrs 22 mins
  • S&P Futures

    4,028.25
    -7.50 (-0.19%)
     
  • Dow Futures

    32,707.00
    -67.00 (-0.20%)
     
  • Nasdaq Futures

    12,836.50
    -30.75 (-0.24%)
     
  • Russell 2000 Futures

    1,790.00
    -3.30 (-0.18%)
     
  • Crude Oil

    69.08
    -0.59 (-0.85%)
     
  • Gold

    1,943.20
    +2.10 (+0.11%)
     
  • Silver

    22.51
    +0.09 (+0.40%)
     
  • EUR/USD

    1.0782
    +0.0009 (+0.0863%)
     
  • 10-Yr Bond

    3.6060
    0.0000 (0.00%)
     
  • Vix

    22.07
    -2.08 (-8.61%)
     
  • GBP/USD

    1.2279
    +0.0060 (+0.4899%)
     
  • USD/JPY

    132.5090
    +0.0490 (+0.0370%)
     
  • BTC-USD

    28,205.24
    +579.09 (+2.10%)
     
  • CMC Crypto 200

    613.90
    +8.85 (+1.46%)
     
  • FTSE 100

    7,536.22
    0.00 (0.00%)
     
  • Nikkei 225

    27,466.61
    +520.94 (+1.93%)
     

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed

  • According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be waning in Europe and the U.S.

  • Public-health experts said they remain cautious about whether the outbreak has peaked as efforts continue to stretch limited vaccine supplies and protect vulnerable individuals.

  • If anything, we need to continue to strongly communicate and educate the public about this pathogen,” said Rodney Rohde, a public-health expert at Texas State University.

  • Related: Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies.

  • According to CDC statistics, at least 46,337 monkeypox cases have been reported in about 90 countries. While Europe was hit hard early on, the U.S. now has roughly one-third of the known cases. The CDC said about 17,000 cases had been reported in the U.S.

  • The World Health Organization said monkeypox cases globally declined 21% last week, after a month-long trend of rising infections.

  • Some U.S. experts believe cases are starting to decline mainly based on immunity from prior infection and behavior changes as awareness of the disease has grown.

  • Photo Jernej Furman from Flickr

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.